Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2

Arthritis and Rheumatism

Volumn 65, Issue 5, 2013, Pages 1271-1281

  Manferdini, Cristina ^a   Maumus, Marie ^b   Gabusi, Elena ^a   Piacentini, Anna ^a   Filardo, Giuseppe ^a   Peyrafitte, Julie Anne ^c   Jorgensen, Christian ^d   Bourin, Philippe ^c   Fleury Cappellesso, Sandrine ^c   Facchini, Andrea ^e   Noël, Danièle ^b   Lisignoli, Gina ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b INSERM   (France)

^c CSA21   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CXCL1 CHEMOKINE; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; GALECTIN 1; INDOLEAMINE 2,3 DIOXYGENASE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOSE DERIVED MESENCHYMAL STEM CELL; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE CELL; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MALE; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; SYNOVIOCYTE;

ADIPOCYTES; AGED; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHEMOKINES; CHONDROCYTES; COCULTURE TECHNIQUES; DINOPROSTONE; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; OSTEOARTHRITIS; SYNOVIAL MEMBRANE;

EID: 84876577485     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37908     Document Type: Article

References (51)

1. Loeser RF, Goldring SR, Scanzello CR, Goldring MB,. Osteoarthritis: a disease of the joint as an organ [review]. Arthritis Rheum 2012; 64: 1697-707.
2. Sellam J, Berenbaum F,. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010; 6: 625-35.
3. Goldring MB, Otero M, Tsuchimochi K, Ijiri K, Li Y,. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis 2008; 67 Suppl 3: iii75-82.
4. Scanzello CR, Goldring SR,. The role of synovitis in osteoarthritis pathogenesis. Bone 2012; 51: 249-57.
5. Hunter DJ,. Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat Rev Rheumatol 2011; 7: 13-22.
6. Prockop DJ,. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-4.
7. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-28.
8. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH,. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103: 1669-75.
9. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
10. Caplan AI, Correa D,. The MSC: an injury drugstore. Cell Stem Cell 2011; 9: 11-5.
11. Prockop DJ, Oh JY,. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 2012; 20: 14-20.
12. Hoogduijn MJ, Popp F, Verbeek R, Masoodi M, Nicolaou A, Baan C, et al. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol 2010; 10: 1496-500.
13. Djouad F, Bouffi C, Ghannam S, Noel D, Jorgensen C,. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol 2009; 5: 392-9.
14. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-86.
15. Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 2010; 59: 1662-9.
16. Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, et al. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 2012; 11: 150-6.
17. Le Blanc K, Mougiakakos D,. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 2012; 12: 383-96.
18. Jorgensen C, Noel D,. Mesenchymal stem cells in osteoarticular diseases. Regen Med 2011; 6: 44-51.
19. Murphy JM, Fink DJ, Hunziker EB, Barry FP,. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48: 3464-74.
20. Grigolo B, Lisignoli G, Desando G, Cavallo C, Marconi E, Tschon M, et al. Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. Tissue Eng Part C Methods 2009; 15: 647-58.
21. Diekman BO, Wu CL, Louer CR, Furman BD, Hueber JL, Kraus VB, et al. Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents post-traumatic arthritis. Cell Transplant 2012. E-pub ahead of print.
22. Ter Huurne M, Schelbergen R, Blattes R, Blom A, de Munter W, Grevers LC, et al. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum 2012; 64: 3604-13.
23. Desando G, Cavallo C, Sartoni F, Martini L, Parrilli A, Veronesi F, et al. Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model. Arthritis Res Ther 2013; 15: R22.
24. Rodriguez AM, Elabd C, Amri EZ, Ailhaud G, Dani C,. The human adipose tissue is a source of multipotent stem cells. Biochimie 2005; 87: 125-8.
25. Awad HA, Wickham MQ, Leddy HA, Gimble JM, Guilak F,. Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials 2004; 25: 3211-22.
26. Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T, et al. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 2004; 6: 7-14.
27. Strem BM, Hicok KC, Zhu M, Wulur I, Alfonso Z, Schreiber RE, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005; 54: 132-41.
28. Kellgren JH, Lawrence JS,. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502.
29. Bourin P, Peyrafitte JA, Fleury-Cappellesso S,. A first approach for the production of human adipose tissue-derived stromal cells for therapeutic use. Methods Mol Biol 2011; 702: 331-43.
30. Grigolo B, Roseti L, Neri S, Gobbi P, Jensen P, Major EO, et al. Human articular chondrocytes immortalized by HPV-16 E6 and E7 genes: maintenance of differentiated phenotype under defined culture conditions. Osteoarthritis Cartilage 2002; 10: 879-89.
31. Lisignoli G, Grassi F, Piacentini A, Cocchini B, Remiddi G, Bevilacqua C, et al. Hyaluronan does not affect cytokine and chemokine expression in osteoarthritic chondrocytes and synoviocytes. Osteoarthritis Cartilage 2001; 9: 161-8.
32. Yanez R, Oviedo A, Aldea M, Bueren JA, Lamana ML,. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp Cell Res 2010; 316: 3109-23.
33. Foraker JE, Oh JY, Ylostalo JH, Lee RH, Watanabe J, Prockop DJ,. Cross-talk between human mesenchymal stem/progenitor cells (MSCs) and rat hippocampal slices in LPS-stimulated cocultures: the MSCs are activated to secrete prostaglandin E2. J Neurochem 2011; 119: 1052-63.
34. Kronsteiner B, Wolbank S, Peterbauer A, Hackl C, Redl H, van Griensven M, et al. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev 2011; 20: 2115-26.
35. Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noel D,. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 2010; 1: 2.
36. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107: 367-72.
37. Merz D, Liu R, Johnson K, Terkeltaub R,. IL-8/CXCL8 and growth-related oncogene α/CXCL1 induce chondrocyte hypertrophic differentiation. J Immunol 2003; 171: 4406-15.
38. Olivotto E, Vitellozzi R, Fernandez P, Falcieri E, Battistelli M, Burattini S, et al. Chondrocyte hypertrophy and apoptosis induced by GROα require three-dimensional interaction with the extracellular matrix and a co-receptor role of chondroitin sulfate and are associated with the mitochondrial splicing variant of cathepsin B. J Cell Physiol 2007; 210: 417-27.
39. Borzi RM, Mazzetti I, Cattini L, Uguccioni M, Baggiolini M, Facchini A,. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 2000; 43: 1734-41.
40. Bonfield TL, Nolan Koloze MT, Lennon DP, Caplan AI,. Defining human mesenchymal stem cell efficacy in vivo. J Inflamm (Lond) 2010; 7: 51.
41. Appleton I, Tomlinson A, Willoughby DA,. Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv Pharmacol 1996; 35: 27-78.
42. Goldring MB, Otero M, Plumb DA, Dragomir C, Favero M, El Hachem K, et al. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater 2011; 21: 202-20.
43. Tan L, Peng H, Osaki M, Choy BK, Auron PE, Sandell LJ, et al. Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1β. J Biol Chem 2003; 278: 17688-700.
44. Okazaki K, Li J, Yu H, Fukui N, Sandell LJ,. CCAAT/enhancer-binding proteins β and δ mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-1β. J Biol Chem 2002; 277: 31526-33.
45. 2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol 2008; 181: 5082-8.
46. Nishitani K, Ito H, Hiramitsu T, Tsutsumi R, Tanida S, Kitaori T, et al. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes. J Cell Biochem 2010; 109: 425-33.
47. Pillinger MH, Rosenthal PB, Tolani SN, Apsel B, Dinsell V, Greenberg J, et al. Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation. J Immunol 2003; 171: 6080-9.
48. Kaneyama K, Segami N, Sato J, Fujimura K, Nagao T, Yoshimura H,. Prognostic factors in arthrocentesis of the temporomandibular joint: comparison of bradykinin, leukotriene B4, prostaglandin E2, and substance P level in synovial fluid between successful and unsuccessful cases. J Oral Maxillofac Surg 2007; 65: 242-7.
49. 2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. Arthritis Rheum 2009; 60: 513-23.
50. Li TF, Zuscik MJ, Ionescu AM, Zhang X, Rosier RN, Schwarz EM, et al. PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp Cell Res 2004; 300: 159-69.
51. Salgado AJ, Reis RL, Sousa NJ, Gimble JM,. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010; 5: 103-10.